[1] Varga J, Greten FR. Cell plasticity in epithelial homeostasis and tumorigenesis[J]. Nat Cell Biol, 2017,19(10):1133-1141. [2] Greten FR, Grivennikov SI. Inflammation and cancer: triggers, mechanisms, and consequences[J]. Immunity, 2019,51(1):27-41. [3] Zitvogel L, Pietrocola F, Kroemer G. Nutrition, inflammation and cancer[J]. Nat Immunol, 2017,18(8):843-850. [4] Mantovani A. The inflammation-cancer connection[J]. FEBS J, 2018,285(4):638-640. [5] Guo Y, Nie Q, MacLean AL, et al. Multiscale modeling of inflammation-induced tumorigenesis reveals competing oncogenic and oncoprotective roles for inflammation[J]. Cancer Res, 2017,77(22):6429-6441. [6] Murata M. Inflammation and cancer[J]. Environ Health Prev Med, 2018,23(1):50-58. [7] 郭靓, 钱露, 郭宁. 炎症—肿瘤恶性演进的推手[J].中国肿瘤生物治疗杂志,2013,20(3):259-265. Guo L, Qian L, Guo N. Inflammation: a promoter in malignant progression of tumor[J]. Chinese Journal of Cancer Biotherapy, 2013,20(3):259-265. [8] 蓝姝, 郑川, 祝捷, 等. 基于“津液”论炎-癌转化[J].中国中医基础医学杂志,2018,24(5):614-615. Lan S, Zheng C, Zhu J, et al. Discussion on inflammatory-cancer transformation based on “body fluid”[J]. Journal of Basic Chinese Medicine, 2018,24(5):614-615. [9] Lee H, Jeong AJ, Ye SK. Highlighted STAT3 as a potential drug target for cancer therapy[J]. BMB Rep, 2019,52(7):415-423. [10] 音金萍, 岳紫晨, 卓少元. STAT3:慢性炎症介导肝癌进程的关键分子[J].临床肝胆病杂志,2020,36(4):948-952. Yin JP, Yue ZC, Zhuo SY. STAT3: A key molecule in the progression of liver cancer mediated by chronic inflammation[J]. Journal of Clinical Hepatology, 2020,36(4):948-952. [11] Taniguchi K, Karin M. NF-kappaB, inflammation, immunity and cancer: coming of age[J]. Nat Rev Immunol, 2018,18(5):309-324. [12] 袁嘉嘉, 孙志广. 论“炎-癌转化”的中医病因病机[J].吉林中医药,2016,36(1):5-8. Yuan JJ, Sun ZG. Theory of etiology and pathogenesis of “inflammation-cancer transformation”[J]. Jilin Journal of Chinese Medicine, 2016,36(1):5-8. [13] Hinshaw DC, Shevde LA. The tumor microenvironment innately modulates cancer progression[J]. Cancer Res, 2019,79(18):4557-4566. [14] 魏智民, 孙玉发, 李刚, 等. 癌症相关性炎症与肿瘤微环境相关研究进展[J].中国肿瘤临床,2018,45(21):1117-1121. Wei ZM, Sun YF, Li G, et al. Advances of research in cancer-associated inflammation and tumor microenvironments[J]. Chinese Journal of Clinical Oncology, 2018,45(21):1117-1121. [15] 沈政洁, 程海波, 沈卫星, 等. 肿瘤炎性微环境与“癌毒”病机相关性探讨[J].北京中医药大学学报,2015,38(1):14-17. Shen ZJ, Cheng HB, Shen WX, et al. Correlation between tumor inflammatory microenvironment and “cancerous toxin” pathogenesis[J]. Journal of Beijing University of Traditional Chinese Medicine, 2015,38(1):14-17. [16] Sawa-Wejksza K, Kandefer-Szerszen M. Tumor-associated macrophages as target for antitumor therapy[J]. Arch Immunol Ther Exp (Warsz), 2018,66(2):97-111. [17] Li F, Zhao Y, Wei L, et al. Tumor-infiltrating Treg, MDSC,and IDO expression associated with outcomes of neoadjuvant chemotherapy of breast cancer[J]. Cancer Biol Ther, 2018,19(8):695-705. [18] 马萌. 肿瘤微环境及其中医证本质—中医现代化路径之探索[J].中华中医药杂志,2018,33(6):2255-2261. Ma M. Tumor microenvironment and the essence of its traditional Chinese medicine syndrome: exploration of the approach to the modernization of traditional Chinese medicine[J]. China Journal of Traditional Chinese Medicine and Pharmacy, 2018,33(6):2255-2261. [19] 张天涵, 沈洪. 溃疡性结肠炎及其中医辨证分型与炎症活动性指标的相关性分析[J].北京中医药大学报,2019,42(8):685-690. Zhang TH, Shen H. Ulcerative colitis and its TCM pattern-differentiation classification and inflammatory activity indexes: a correlation analysis[J]. Journal of Beijing University of Traditional Chinese Medicine, 2019,42(8):685-690. [20] 王婷, 郑锋玲, 骆欢欢. 岭南温病湿热证小鼠模型的建立及肠道菌群的研究分析[J].中华中医药学刊,2017,35(6):1361-1365. Wang T, Zheng FL, Luo HH. Establishment of febrile disease damp-heat syndrome mice models in south of the five ridges and analysis on intestinal flora[J]. Chinese Archives of Traditional Chinese Medicine, 2017,35(6):1361-1365. [21] 吴智兵, 彭胜权, 舒彤. 湿热环境在湿温发病中的作用机理探讨[J].上海中医药杂志,2003,37(12):45-46. Wu ZB, Peng SQ, Shu T. Effects of damp-heat environment in the occurrence of damp-warm disorders[J]. Shanghai Journal of Traditional Chinese Medicine, 2003,37(12):45-46. [22] 李琦玮, 于明薇, 王笑民. 癌毒理论研究现状[J].中医杂志,2015,56(4):347-350. Li QW, Yu MW, Wang XM. Research status of cancer toxicity theory[J]. Journal of Traditional Chinese Medicine, 2015,56(4):347-350. [23] 王书杰, 韦艾凌. 肝癌“湿热伏邪”—“癌毒”发病机制及疗法探讨[J].中国中西医结合杂志,2013,33(2):266-269. Wang SJ, Wei AL. Exploring the pathogenesis and therapy of liver cancer from “damp-heat insidious pathogen” to “cancer toxin”[J]. Chinese Journal of Integrated Traditional and Western Medicine, 2013,33(2):266-269. [24] 谢丹枫, 周泽豪, 陈紫莹, 等. 湿热证与肿瘤发生发展相关性研究进展[J].环球中医药,2019,12(12):1949-1954. Xie DF, Zhou ZH, Chen ZY, et al. Research advances on the relevance between cancer development and dampness-heat syndrome[J]. Global Traditional Chinese Medicine, 2019,12(12):1949-1954. [25] 刘宣, 季青, 柴妮, 等. 湿热因素对结肠癌血管新生与肝转移的影响[J].中华中医药杂志,2015,30(6):1934-1937. Liu X, Ji Q, Chai N, et al. Effects of dampness-heat on angiogenesis and liver metastasis in colonic cancer[J]. China Journal of Traditional Chinese Medicine and Pharmacy, 2015,30(6):1934-1937. [26] Siveen KS, Prabhu K, Krishnankutty R, et al. Vascular endothelial growth factor (VEGF) signaling in tumour vascularization: potential and challenges[J]. Curr Vasc Pharmacol, 2017,15(4):339-351. [27] Roy R, Morad G, Jedinak A, et al. Metalloproteinases and their roles in human cancer[J]. Anat Rec (Hoboken), 2020,303(6):1557-1572. [28] 周建红, 胡玲, 邢海伦, 等. Hp相关胃病不同中医证候型EGF、TFF1及ICAM-1蛋白水平的表达[J].时珍国医国药,2013,24(12):3064-3067. Zhou JH, Hu L, Xing HL, et al. The protein expression of EGF, TFF1 and ICAM-1 in Hp-related gastropathy with different TCM syndrome[J]. Lishizhen Medicine and Materia Medica Research, 2013,24(12):3064-3067. [29] Nakamura K, Smyth MJ. Targeting cancer-related inflammation in the era of immunotherapy[J]. Immunol Cell Biol, 2017,95(4):325-332. |